Others recently demonstrated greatly accelerated formation of low-grade (G1/G2) insulinomas in mice with targeted inactivation of both Men1 and Pten, with an onset of pNETs at 7 weeks of age [65]. The gene discussed is PTEN; the disease is pancreatic insulinoma.